Showing results (1341-1350 of 6,957) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|September 1, 1986
Phase I and II agents in cancer therapy: I. Anthracyclines and related compoundsS Wadler, J Z Fuks, P H WiernikJournal of Clinical Pharmacology|February 21, 2018
Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?Hannah Hoseyni, Yan Xu, Honghui ZhouJournal of Clinical Pharmacology|February 21, 2018
Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended-Release Once-Daily Tacrolimus TabletsBenjamin Philosophe, Nicolae Leca, Patricia M West-Thielke, et al.Journal of Clinical Pharmacology|January 30, 2020
Reversing the Effects of 0.5% Bupivacaine Using Phentolamine Mesylate: A Preliminary Randomized Controlled Clinical TrialPierre-Luc Michaud, Erin Nowe, Martha Smith BrillantJournal of Clinical Pharmacology|September 23, 2014
Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusionsAgnieszka Bienert, Katarzyna Wawrzyniak, Paweł Wiczling, et al.Journal of Clinical Pharmacology|September 5, 2014
Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's diseaseChuanpu Hu, Omoniyi Adedokun, Kaori Ito, et al.Journal of Clinical Pharmacology|August 30, 2014
Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: a randomized clinical trialMahvash Shere, Patricia Nguyen, Carolyn Tam, et al.Journal of Clinical Pharmacology|August 22, 2014
Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: laropiprant in comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosaceaRajesh Krishna, Ying Guo, Valerie Schulz, et al.Journal of Clinical Pharmacology|March 9, 2016
Use of Antipsychotics for the Treatment of Behavioral Symptoms of DementiaH Karl Greenblatt, David J GreenblattJournal of Clinical Pharmacology|September 5, 2020
Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort StudyJohn Ferguson, Stacy Volk, Thomas Vondracek, et al.Pageof 696